InvestorsHub Logo
Followers 23
Posts 2140
Boards Moderated 1
Alias Born 07/07/2009

Re: None

Thursday, 12/12/2019 7:29:50 PM

Thursday, December 12, 2019 7:29:50 PM

Post# of 253
Phase 3 trials underway to be completed in June 2020. Results in Q4 2020.

https://clinicaltrials.gov/ct2/show/NCT03703882?term=edasalonexent&cond=Duchenne+Muscular+Dystrophy